Cargando…

Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy

Antigenic diversity of the M protein is a major constraint to the development of immunity to group A streptococcus (GAS). We demonstrate that a conserved cryptic epitope that is unrecognized by the host immune system following infection can protect mice following vaccination, and that immunity is st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Manisha, Ozberk, Victoria, Langshaw, Emma L., Calcutt, Ainslie, Powell, Jessica, Batzloff, Michael R., Rivera-Hernandez, Tania, Good, Michael F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920117/ https://www.ncbi.nlm.nih.gov/pubmed/29736269 http://dx.doi.org/10.1038/s41541-018-0053-9

Ejemplares similares

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
por: Reynolds, Simone, et al.
Publicado: (2021)

Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma
por: Pandey, Manisha, et al.
Publicado: (2016)

Novel platform technology for modular mucosal vaccine that protects against streptococcus
por: Zaman, Mehfuz, et al.
Publicado: (2016)

Contribution of cryptic epitopes in designing a group A streptococcal vaccine
por: Ozberk, Victoria, et al.
Publicado: (2018)

Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus
por: Chen, Shuxiong, et al.
Publicado: (2023)

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
por: Ozberk, Victoria, et al.
Publicado: (2023)

Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models
por: Langshaw, Emma L., et al.
Publicado: (2023)

Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial
por: Pandey, Manisha, et al.
Publicado: (2017)

Mechanism of Protection Induced by Group A Streptococcus Vaccine Candidate J8-DT: Contribution of B and T-Cells Towards Protection
por: Pandey, Manisha, et al.
Publicado: (2009)

Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes
por: Ozberk, Victoria, et al.
Publicado: (2021)

Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice
por: Pandey, Manisha, et al.
Publicado: (2019)

M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)
por: Mills, Jamie-Lee S., et al.
Publicado: (2020)

Pneumococcal Phasevarions Control Multiple Virulence Traits, Including Vaccine Candidate Expression
por: Phillips, Zachary N., et al.
Publicado: (2022)

Immunological Evaluation of Lipopeptide Group A Streptococcus (GAS) Vaccine: Structure-Activity Relationship
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial
por: Sekuloski, Silvana, et al.
Publicado: (2018)

Author Correction: M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)
por: Mills, Jamie-Lee S., et al.
Publicado: (2020)

Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super‐infection
por: Zaman, Mehfuz, et al.
Publicado: (2021)

The quest for GAS vaccine
por: Pandey, Manisha, et al.
Publicado: (2015)

Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2
por: Pandey, Manisha, et al.
Publicado: (2021)

“Breathing” Hemagglutinin Reveals Cryptic Epitopes for Universal Influenza Vaccine Design
por: Wu, Yan, et al.
Publicado: (2019)

Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model
por: Reynolds, Simone, et al.
Publicado: (2023)

Broadening the repertoire of melanoma-associated T-cell epitopes
por: Frøsig, Thomas Mørch, et al.
Publicado: (2015)

An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model
por: Rivera-Hernandez, Tania, et al.
Publicado: (2019)

Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models
por: Rivera-Hernandez, Tania, et al.
Publicado: (2016)

Structure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A Streptococcus
por: Henningham, Anna, et al.
Publicado: (2013)

Erratum for Rivera-Hernandez et al., “An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model”
por: Rivera-Hernandez, Tania, et al.
Publicado: (2020)

Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes
por: Rajesh Kumar, Subaschandrabose, et al.
Publicado: (2017)

Vaccine immune boost
por: Le Page, Michael
Publicado: (2020)

High frequency of T cells specific for cryptic epitopes in melanoma patients
por: Andersen, Rikke Sick, et al.
Publicado: (2013)

Predicting Promiscuous T Cell Epitopes for Designing a Vaccine Against Streptococcus pyogenes
por: Ebrahimi, Samira, et al.
Publicado: (2018)

Broadening the horizons for yellow fever: new uses for an old vaccine
por: Van Epps, Heather L.
Publicado: (2005)

How can cryptic epitopes trigger autoimmunity?
Publicado: (1995)

An immunoinformatics approach to epitope-based vaccine design against PspA in Streptococcus pneumoniae
por: Mazumder, Lincon, et al.
Publicado: (2023)

Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
por: Walters, Jewell N., et al.
Publicado: (2022)

Dm Determines the Cryptic and Immunodominant Fate of T Cell Epitopes
por: Nanda, Navreet K., et al.
Publicado: (2000)

Generation of a Peptide Vaccine Candidate against Falciparum Placental Malaria Based on a Discontinuous Epitope
por: Mitran, Catherine J., et al.
Publicado: (2020)

Development and evaluation of a multi-epitope subunit vaccine against group B Streptococcus infection
por: Zhang, Yumin, et al.
Publicado: (2022)

A DNA-Modified Live Vaccine Prime–Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus
por: Bernelin-Cottet, Cindy, et al.
Publicado: (2019)

COVID-19 Vaccine Booster: To Boost or Not to Boost
por: Shekhar, Rahul, et al.
Publicado: (2021)

A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria
por: Pritam, Manisha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rgikk575kien6h0tk354kflm9n